During the past decade, Detweiler Family Medicine conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 14 clinical trials were completed, i.e. on average, 107.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 9 clinical trials were completed. i.e. 225% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Detweiler Family Medicine" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Pfizer" with 3 trials sponsored, "Advanced Laboratory Services, Inc." with 1 trials sponsored, "AltheaDx" with 1 trials sponsored and "Biota Scientific Management Pty Ltd" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Detweiler Family Medicine" #1 collaborator was "Department of Health and Human Services" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Innovis LLC" with 1 trials as a collaborator, "Janssen, LP" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Detweiler Family Medicine" are "Cardiovascular Disease" (4 trials), "Obesity" (3 trials), "Overweight" (3 trials), "Diabetes Mellitus, Type 2" (2 trials) and "Hyperlipidemia" (2 trials). Many other conditions were trialed in "Detweiler Family Medicine" in a lesser frequency.

Most popular intervention types in "Detweiler Family Medicine" are "Drug" (18 trials), "Other" (3 trials), "Device" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Tirzepatide" (5 trials), "bococizumab (PF-04950615)" (2 trials), "40 mg Laninamivir Octanoate" (1 trials) and "80 mg Laninamivir Octanoate" (1 trials). Other intervention names were less common.

The vast majority of trials in "Detweiler Family Medicine" are 21 trials for "All" genders.

Currently, there are NaN active trials in "Detweiler Family Medicine". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Detweiler Family Medicine, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Detweiler Family Medicine, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".